Phoenix Biotech Acquisition Corp. (PBAXW) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The current CEO is Christopher B. Ehrlich.
PBAXW has listed on the NASDAQ Global Market, a market capitalization of $375.83K.
No company description available.
